Please join us for an exclusive webinar highlighting groundbreaking research from the Hebrew University’s chemical biology laboratory. This event will feature Dr. Raphael Benhamou, who will present his pioneering work on RNA-targeted therapies.
As an Assistant Professor at HU’s School of Pharmacy, Dr. Raphael Benhamou has led cutting-edge research since 2021. His previous experience includes post-doctoral research at Scripps Research Institute, where he focused on designing small molecules targeting RNAs. Dr. Benhamou focuses on the role of RNA in disease, using organic chemistry to create small molecules that bind to and modify specific RNA motifs. These molecules function as both probes for studying RNA complexes and potential drugs for treating diseases ranging from cancer to infectious diseases.